Ascendis Pharma A (ASND) Convertible Debt (2021 - 2025)
Ascendis Pharma A (ASND) reported Convertible Debt of $206.81 million for the quarter ended Mar 31, 2026, up 105.3% from $100.74 million a year earlier but down 58.6% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Convertible Debt (2021 - 2025) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A posted Convertible Debt of $485.13 million, up 352.1% from the prior year.
- Convertible Debt has increased for four consecutive years, with a four-year compound annual growth rate of 334.2% (years ended Dec 2021 to Dec 2025).
- By year, Convertible Debt came in at $107.31 million in the year ended Dec 31, 2024 (+203.2%), $35.39 million in the year ended Dec 31, 2023 (+357.6%), $7.73 million in the year ended Dec 31, 2022 (+466.8%) and $1.36 million in the year ended Dec 31, 2021.
- Five-year quarterly Convertible Debt spans a low of $1.36 million in the quarter ended Dec 31, 2021 and a high of $499.83 million in the quarter ended Dec 31, 2025.
- Year over year, Convertible Debt has now increased in each of the last 14 quarters, with growth averaging 270.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Convertible Debt ran from 46.3% in the quarter ended Sep 30, 2025 to 876.7% in the quarter ended Jun 30, 2024.
- Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $499.83 million (quarter ended Dec 31, 2025), $161.07 million (quarter ended Sep 30, 2025) and $169.72 million (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,162.99 Bn | 1,131.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 633.71 Bn | 552.23 Bn | 17.26 Bn |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn |
| 4 | Merck | 376.48 Bn | 330.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.02 Bn | 240.70 Bn | 12.86 Bn |
| 7 | Amgen | 240.85 Bn | 196.25 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.39 Bn | 167.58 Bn | 6.22 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn |
| 10 | Ascendis Pharma A | 14.52 Bn | 10.79 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 504.42 Mn |
| Dec 31, 2024 | 476.82 Mn |
| Dec 31, 2022 | 425.56 Mn |
| Dec 31, 2021 | 569.97 Mn |
API Access
Ascendis Pharma A Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();